cancer clinical trials in alabama
|
Children's Hospital of Alabama
Birmingham, Alabama 35233 Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma, Recurrent Childhood Anaplastic Oligodendroglioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Diffuse Astrocytoma, Recurrent Childhood Fibrillary Astrocytoma, Recurrent Childhood Gemistocytic Astrocytoma, Recurrent Childhood Giant Cell Glioblastoma, Recurrent Childhood Glioblastoma, Recurrent Childhood Gliomatosis Cerebri, Recurrent Childhood Gliosarcoma, Recurrent Childhood Oligoastrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Pineoblastoma, Recurrent Childhood Pleomorphic Xanthoastrocytoma, Recurrent Childhood Protoplasmic Astrocytoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma, Unspecified Childhood Solid Tumor, Protocol Specific
|
|
Clearview Cancer Institute
Huntsville, Alabama 35805 Chronic Lymphocytic Leukemia
|
|
Clearview Cancer Institute
Huntsville, Alabama 35805 Chronic Lymphocytic Leukemia
|
|
University of Alabama at Birmingham
Trial Locations University of Alabama at Birmingham Children's Hospital of Alabama Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma
|
|
Clearview Cancer Institute
Huntsville, Alabama 35805 Chronic Lymphocytic Leukemia
|
|
Investigational Site Number 840-002
Muscle Shoals, Alabama 35661 Colorectal Cancer Metastatic
|
|
Southern Cancer Center PC
Mobile, Alabama 36608 Breast Cancer
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Brain Tumor
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Cushing's Disease
|
|
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Birmingham, Alabama 35294 Glioblastoma
|
|
Investigational Site Number 840010
Birmingham, Alabama 35205 Neoplasm Malignant
|
|
UAB
Birmingham, Alabama 35294 HIV, Osteoporosis
|
|
Investigational Site Number 840013
Birmingham, Alabama 35205 Solid Tumors
|
|
Children's Hospital of Alabama
Trial Locations Children's Hospital of Alabama University of South Alabama B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
|
|
University of South Alabama
Mobile, Alabama 36693 Sickle Cell Disease, Sickle Cell Anemia, Sickle Cell Disorders, Hemoglobin S Disease, Sickling Disorder Due to Hemoglobin S
|
|
Radiant Research
Trial Locations Radiant Research Birmingham Heart Clinic Central Alabama Research Digestive Health Specialists of the Southeast Coastal Clinical Research Obesity, Overweight
|
|
Birmingham, Alabama 35294 Prostate Cancer, Castration Resistant Prostate Cancer, Pain, Prostatic Neoplasms
|
|
University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2)
Mobile, Alabama 36688 Breast Cancer
|
|
Birmingham, Alabama 35294 Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
|
|
Birmingham, Alabama 35294 Breast Cancer
|
|
University of Alabama at Birmingham
Trial Locations University of Alabama at Birmingham The Kirklin Clinic at Acton Road HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Tumors Metastatic to Brain
|
|
TG Therapeutics Investigational Trial Site
Huntsville, Alabama 35805 Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Primary Central Nervous System Lymphoma
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Renal Cell Carcinoma
|
|
1200.45.004 Boehringer Ingelheim Investigational Site
Mobile, Alabama Carcinoma, Non-Small-Cell Lung
|
|
Achieve Clinical Research, LLC
Tuscaloosa, Alabama 35406 Pain, Peripheral Neuropathy, Neuropathic Pain
|
|
Site Reference ID/Investigator# 68495
Birmingham, Alabama 35233 Brain Metastases From Non-small Cell Lung Cancer
|
|
Birmingham, Alabama 35294 Lymphoma, Non-Hodgkin
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Malignant Peripheral Nerve Sheath Tumors, MPNST, Sarcoma
|
|
Birmingham, Alabama 35294 Prostate Cancer
|
|
Birmingham, Alabama 35294 Malignant Melanoma
|
|
Universeity of Alabama Cancer Center
Birmingham, Alabama 35294 Breast Neoplasms
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Cholangiocarcinoma
|
|
Synta Pharmaceuticals Investigative Site
Birmingham, Alabama 35249 Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer
|
|
Lexicon Investigational Site
Mobile, Alabama 36604 Carcinoid Syndrome
|
|
Birmingham, Alabama 35294 Malignant Melanoma
|
|
Research Site
Alabaster, Alabama N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
|
|
Birmingham, Alabama 35294 Prostate Cancer
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 High Risk Acute Myeloid Leukemia
|
|
University of Alabama Comprehensive Cancer Center SC
Birmingham, Alabama 35294 Hormone Receptor Positive Breast Cancer
|
|
GSK Investigational Site
Birmingham, Alabama 35209 Systemic Lupus Erythematosus
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Medulloblastoma
|
|
Local Institution
Birmingham, Alabama Melanoma
|
|
Children's Hospital of Alabama
Birmingham, Alabama 35233 Recurrent Melanoma, Recurrent Thyroid Cancer, Thyroid Gland Medullary Carcinoma, Unspecified Childhood Solid Tumor, Protocol Specific
|
|
Investigational Site Number 840070
Trial Locations Investigational Site Number 840070 Investigational Site Number 840138 Rheumatoid Arthritis
|
|
University of Alabama at Birmingham SC
Birmingham, Alabama 35294 Tuberous Sclerosis Complex-associated Refractory Seizures
|
|
University of Alabama at Birmingham (UAB)
Birmingham, Alabama 35233 Lupus Nephritis
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Hodgkin Disease
|
|
Investigational Site Number 840003
Birmingham, Alabama 35294-3300 Prostate Cancer Metastatic
|
|
Children's Hospital of Alabama
Birmingham, Alabama 35233 Unspecified Childhood Solid Tumor, Protocol Specific
|
|
University of Alabama - Birmingham
Birmingham, Alabama 35294 Cutaneous T-Cell Lymphoma
|
|
University of Alabama at Birmingham
Birmingham, Alabama 35294-3300 Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
|
|
Clearview Cancer Center
Huntsville, Alabama 35801 Leukemia Lymphocytic Chronic B-Cell
|
|
Clearview Cancer Institute
Huntsville, Alabama 35805 Indolent Non-Hodgkin's Lymphomas
|
|
Clearview Cancer Institute
Huntsville, Alabama 35805 Indolent Non-Hodgkin's Lymphomas
|
|
Clearview Cancer Institute
Huntsville, Alabama 35805 Leukemia Lymphocytic Chronic B-Cell
|
|
University of Alabama Comprehensive Cancer Center University of Alabama (8)
Birmingham, Alabama 35294 CML
|
